Semaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with type 1 diabetes (T1D) who are living with overweight or obesity ...

Researchers at the University of Copenhagen have identified a promising new drug target for weight loss which could revolutionise treatment for millions of people with obesity and type 2 diabetes. The ...

Real-Life Weight Loss Story ... Battling multiple health issues, including type 1 diabetes, Polycystic Ovary Syndrome (PCOS), ...

GLP-1 medications, like semaglutide (Ozempic) or tirzepatide (Mounjaro), can help control blood sugar and promote weight loss for people with type 2 diabetes, but they are just one part of a ...

part of a new category of weight loss medication called glucagon-like peptide 1, or GLP-1 drugs, which are approved to treat Type 2 diabetes. Drug companies have invested hundreds of millions of ...

Prescriptions of GLP-1RAs and SGLT2 inhibitors in type 1 diabetes patients rose from ... ketoacidosis and concerns about significant weight loss. Further research is needed to evaluate the safety ...

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

Bariatric surgery, one common type of which is gastric sleeve ... while 242 received GLP-1 diabetes drugs, which also promote weight loss. Participants were followed for a median of 5.8 years.